Galyna A. Kutsyna

Luhansk, Ukraine

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

Effect of degalactosylated bovine glycoprotein formulations MAF and M сapsules on lymphopenia and clinical outcomes in hospitalized COVID-19 patients: a randomized clinical trial.

Effect of degalactosylated bovine glycoprotein formulations MAF and M сapsules on lymphopenia and clinical outcomes in hospitalized COVID-19 patients: a randomized clinical trial.

Journal: BMC infectious diseases
Published: April 29, 2023

Improving the evidence for indicator condition guided HIV testing in Europe: Results from the HIDES II Study - 2012 - 2015.

Improving the evidence for indicator condition guided HIV testing in Europe: Results from the HIDES II Study - 2012 - 2015.

Journal: PloS one
Published: October 26, 2018

Open-label Phase II clinical trial in 75 patients with advanced hepatocellular carcinoma receiving daily dose of tableted liver cancer vaccine, hepcortespenlisimut-L.

Open-label Phase II clinical trial in 75 patients with advanced hepatocellular carcinoma receiving daily dose of tableted liver cancer vaccine, hepcortespenlisimut-L.

Journal: Journal of hepatocellular carcinoma
Published: April 27, 2017

Double-blind, placebo-controlled, 1:1 randomized Phase III clinical trial of Immunoxel honey lozenges as an adjunct immunotherapy in 269 patients with pulmonary tuberculosis.

Double-blind, placebo-controlled, 1:1 randomized Phase III clinical trial of Immunoxel honey lozenges as an adjunct immunotherapy in 269 patients with pulmonary tuberculosis.

Journal: Immunotherapy
Published: November 22, 2016

The cardiovascular risk management for people living with HIV in Europe: how well are we doing?

The cardiovascular risk management for people living with HIV in Europe: how well are we doing?

Journal: AIDS (London, England)
Published: July 27, 2016

Auditing HIV Testing Rates across Europe: Results from the HIDES 2 Study.

Auditing HIV Testing Rates across Europe: Results from the HIDES 2 Study.

Journal: PloS one
Published: May 12, 2015

Multidrug-resistant tuberculosis in Ukraine at a time of military conflict.

Multidrug-resistant tuberculosis in Ukraine at a time of military conflict.

Journal: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease
Published: April 11, 2015

The prevalence and predictive value of dipstick urine protein in HIV-positive persons in Europe.

The prevalence and predictive value of dipstick urine protein in HIV-positive persons in Europe.

Journal: Journal of the International AIDS Society
Published: November 14, 2014

Randomized, placebo-controlled Phase II trial of heat-killed Mycobacterium vaccae (Immodulon batch) formulated as an oral pill (V7).

Randomized, placebo-controlled Phase II trial of heat-killed Mycobacterium vaccae (Immodulon batch) formulated as an oral pill (V7).

Journal: Immunotherapy
Published: October 04, 2013

Randomized, placebo-controlled phase II trial of heat-killed Mycobacterium vaccae (Longcom batch) formulated as an oral pill (V7).

Randomized, placebo-controlled phase II trial of heat-killed Mycobacterium vaccae (Longcom batch) formulated as an oral pill (V7).

Journal: Human vaccines & immunotherapeutics
Published: June 21, 2013

Adjunct immune therapy of first-diagnosed TB, relapsed TB, treatment-failed TB, multidrug-resistant TB and TB/HIV.

Adjunct immune therapy of first-diagnosed TB, relapsed TB, treatment-failed TB, multidrug-resistant TB and TB/HIV.

Journal: Immunotherapy
Published: August 03, 2012

Clinical validation of sublingual formulations of Immunoxel (Dzherelo) as an adjuvant immunotherapy in treatment of TB patients.

Clinical validation of sublingual formulations of Immunoxel (Dzherelo) as an adjuvant immunotherapy in treatment of TB patients.

Journal: Immunotherapy
Published: March 10, 2012
Showing 1-12 of 14

Last Updated: 09/26/2026